Association between CD209 -336A/G and -871A/G Polymorphisms and Susceptibility of Tuberculosis: A Meta-Analysis

Abstract

Background

The association between CD209 promoter polymorphisms (-336A/G, -871A/G) and tuberculosis (TB) risk has been widely reported, but results of previous studies remain controversial and ambiguous. To assess the association between CD209 polymorphisms and TB risk, a meta-analysis was performed.

Methods

Based on comprehensive searches of the PubMed, Embase, Web of Science, Weipu, and CBM databases, we identified outcome data from all articles estimating the association between CD209 polymorphisms and TB risk. The pooled odds ratio (OR) with 95% confidence intervals (CIs) were calculated.

Results

A total of 14 studies with 3,610 cases and 3,539 controls were identified. There was no significant association between CD209 -336A/G polymorphism and TB risk (OR = 1.04, 95% CI = 0.91–1.19 for G vs. A; OR = 1.13, 95% CI = 0.84–1.53 for GG vs. AA; OR = 1.04, 95% CI = 0.87–1.24 for GG+AG vs. AA; OR = 1.11, 95% CI = 0.88–1.39 for GG vs. AG+AA). However, the significant association was revealed for Asians in GG vs. AA (OR = 2.48, 95% CI = 1.46–4.22, P = 0.0008) and GG vs. AG+AA (OR = 2.10, 95% CI = 1.33–3.32, P = 0.001). For the CD209 -871A/G polymorphism, lack of an association was also found (OR = 0.81, 95% CI = 0.70–0.95 for G vs. A; OR = 1.00, 95% CI = 0.52–1.93 for GG vs. AA; OR = 0.73, 95% CI = 0.60–0.89 for GG+AG vs. AA; OR = 1.09, 95% CI = 0.57–2.10 for GG vs. AG+AA).

Conclusion

The present meta-analysis suggested that CD209 promoter polymorphisms (-336A/G, -871A/G) were unlikely to substantially contribute to TB susceptibility. However, the GG genotype of CD209 -336A/G polymorphism might be a genetic risk factor that increases TB susceptibility for Asians in GG vs. AA and GG vs. AG+AA.

About the Authors:

Kai Chang

Contributed equally to this work with: Kai Chang, Shaoli Deng

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Shaoli Deng

Contributed equally to this work with: Kai Chang, Shaoli Deng

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Weiping Lu

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Feng Wang

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Shuangrong Jia

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Fake Li

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Lili Yu

* E-mail: [email protected] (MC); [email protected] (LY)

Affiliation: Department of Obstetrics and Gynecology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Ming Chen

* E-mail: [email protected] (MC); [email protected] (LY)

Affiliation: Department of Laboratory Medicine, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China

Introduction

Tuberculosis (TB) constitutes a serious threat to public health throughout the world, particularly in developing countries [1]. Recent data from the World Health Organization (WHO) show that nearly 10 million new cases arise and 1.7 million deaths die of TB annually [2]. It has been reported that one-third of population is infected with Mycobacterium tuberculosis; however, only one-tenth of infected individuals will ever develop active TB [3]. Thus, host genetic susceptibility, combined with environmental factors, may play a crucial role in exploring the infection mechanism of Mycobacterium tuberculosis [4]–[5].

The CD209 gene, located on human chromosome 19p13.2–3, is composed of 7 exons and 6 introns, and is about 13 kb in length [6]–[7]. This gene encoded Dendritic Cell-Specific ICAM3-Grabbing Non-integrin (DC-SIGN), which is one of the major receptor of Mycobacterium tuberculosis on human dendritic cells [8]. In addition, the Mycobacterium tuberculosis interacts with DC-SIGN to activate the Raf-1-acetylation-dependent signaling pathway that is involved in the regulation of adaptive immune response to tuberculosis. Furthermore, the DC-SIGN could suppress Toll-like receptor signaling leading to cytokine secretion. This effect may be a part of immune evasion to TB progression [9]–[10]. Therefore, the CD209 gene might play a crucial role in host immunity to TB and might be one of the candidate genes for susceptibility of TB.

A relatively large number of studies evaluated the association between CD209 polymorphisms (-336A/G, -871A/G) and TB risk, but the results have been inconsistent due to limited sample sizes and different study populations. To derive a more comprehensive and precise estimation of the relationship, we carried out a meta-analysis on all eligible case-control studies to estimate the effect of CD209 polymorphisms on the risk of TB and to quantify the potential between-study heterogeneity.

Results

Study Characteristics

Eleven publications, including 3,610 cases and 3,539 controls, met the inclusion criteria [6], [11]–[20]. A flowchart detailing the process for study identification and selection was shown in Fig. S1. The publication of Vannberg et al. presented four independent case-control studies, each study was considered separately for analysis. Therefore, 11 publications including 14 studies were involved in this meta-analysis. The main characteristics of the studies were shown in Table 1. The sample sizes ranged from 273 to 1093 patients (median 390, IQR 324–669). Nine of the 14 included studies reported the proportion of male patients, which ranged from 14.5% to 81.1% (median 62.25%, IQR 53.225%–68.5%). Thirteen of the 14 included studies clearly described the diagnostic criteria. One study didn’t provide the genotype number [18]. Gene frequencies of all the individual studies were shown in Table S1. The NOS scores ranged from 7 to 9, which indicated that the methodological quality was generally good. The quality assessment of included studies was shown in Table S2. The genotype distribution in the controls of all studies was in agreement with HWE.

[Figure omitted. See PDF.]

Table 1. Association between individual study characteristics and CD209 gene polymorphisms.

https://doi.org/10.1371/journal.pone.0041519.t001

The CD209 -336A/G Alleles and Tuberculosis Susceptibility

Random effects models were used to calculate the pooled OR in all genetic models. Overall, the combined results showed that no significant association was found in all genetic models (OR = 1.04, 95% CI = 0.91–1.19 for G vs. A, OR = 1.13, 95% CI = 0.84–1.53 for GG vs. AA, OR = 1.04, 95% CI = 0.87–1.24 for GG+AG vs. AA, and OR = 1.11, 95% CI = 0.88–1.39 for GG vs. AG+AA). Forest plots on the basis of all studies were shown in Fig. 1A, B, C, D. When stratified by ethnicity, we observed a wide variation of G allele frequencies between the controls across different ethnicities. The G allele frequencies were significant difference in Africans, Asians, Caucasians and Mixed populations (P = 0.007). Forest plots were shown in Fig. S2. When meta-analysis was performed to assess association between CD209 -336A/G polymorphism and TB risk in different ethnicities, significant association was revealed for Asians in GG vs. AA (OR = 2.48, 95% CI = 1.46–4.22, P = 0.0008) and GG vs. AG+AA (OR = 2.10, 95% CI = 1.33–3.32, P = 0.001) (Fig. S3, Fig. S4, Fig. S5, and Fig. S6). On subgroup analysis by sample types, no evidence of association was found in all genetic models for pulmonary tuberculosis (PTB) and extra-pulmonary tuberculosis (EPTB). The results were shown in Table 2.

[Figure omitted. See PDF.]

Figure 1. Forest plot of the overall risk of TB associated with the CD209 -336A/G promoter polymorphism.

No significant association was found between the CD209 -336A/G polymorphism and TB risk in all genetic models. A, G vs. A; B, GG vs. AA; C, dominant genetic model; D, recessive genetic model. Error bars indicate 95% CI. Solid squares represent each study in the meta-analysis. Solid diamonds represent pooled OR.

https://doi.org/10.1371/journal.pone.0041519.g001

[Figure omitted. See PDF.]

Table 2. Meta-analyses of CD209 -336A/G promoter polymorphism and risk of TB in each subgroup.

https://doi.org/10.1371/journal.pone.0041519.t002

The CD209 -871A/G Alleles and Tuberculosis Susceptibility

The results on the CD209 -871A/G polymorphism indicated that the G allele had no significant association to TB susceptibility as compared to the A allele under the fixed effects models (Fig. 2). The results were as followed: G vs. A (OR = 0.81, 95% CI = 0.70–0.95), GG vs. AA (OR = 1.00, 95% CI = 0.52–1.93), GG+AG vs. AA (OR = 0.73, 95% CI = 0.60–0.89), GG vs. AG+AA (OR = 1.09, 95% CI = 0.57–2.10).

[Figure omitted. See PDF.]

Figure 2. Forest plot of the overall risk of TB associated with the CD209 -871A/G promoter polymorphism.

No significant association was found between the CD209 -871A/G polymorphism and TB risk in all genetic models. Error bars indicate 95% CI. Solid squares represent each study in the meta-analysis. Solid diamonds represent pooled OR.

https://doi.org/10.1371/journal.pone.0041519.g002

Heterogeneity Analysis

For CD209 -336A/G polymorphism, there were statistically significant heterogeneity in G vs. A (I² = 66%, P_{heterogeneity} = 0.0003), GG vs. AA (I² = 60%, P_{heterogeneity} = 0.003), dominant genetic model (I² = 62%, P_{heterogeneity} = 0.002), and recessive genetic model (I² = 47%, P_{heterogeneity} = 0.03). To explain the heterogeneity, Galbraith plots were performed in all genetic models. The two studies of Zhuang et al. and Vannberg FO(a) et al. were outliers in the G vs. A, GG vs. AA, and recessive genetic model (Fig. 3A, B, D). The three studies of Zhuang et al., Vannberg FO(a) et al. and Barreiro LB et al. were outliers in the dominant genetic model (Fig. 3C). When the studies of Zhuang et al., Vannberg FO(a) et al. and Barreiro LB et al. were excluded respectively, all I² values were less than 50% and P_{heterogeneity} were greater than 0.1 (Table 3). The significant of pooled OR in all genetic models was not influenced after excluding the studies. By meta-regression analysis, the heterogeneity sources were attributed to the sample size, control source, NOS scores, and the frequency of G allele. However, the four above-mentioned factors had no significant impact on pooled OR in all genetic models (Table S3).

[Figure omitted. See PDF.]

Figure 3. Galbraith plot of CD209 -336A/G promoter polymorphism and TB risk.

A, The two studies of Zhuang et al. and Vannberg FO(a) et al. were outliers in G vs. A; B, The two studies of Zhuang et al. and Vannberg FO(a) et al. were outliers in GG vs. AA; C, The three studies of Zhuang et al., Vannberg FO(a) et al. and Barreiro LB et al. were outliers in dominant genetic model; D, The two studies of Zhuang et al. and Vannberg FO(a) et al. were outliers in recessive genetic model.

https://doi.org/10.1371/journal.pone.0041519.g003

[Figure omitted. See PDF.]

Table 3. Meta-analyses of CD209 -336A/G promoter polymorphism and risk of TB after omitting the studies.

https://doi.org/10.1371/journal.pone.0041519.t003

Sensitivity Analysis

Sensitivity analysis was performed though sequential excluding individual studies. Statistically similar results were obtained in all genetic models after sequentially excluding each study, indicated that our dates were stability and liability in this meta-analysis.

Publication Bias

Publication bias was estimated by the funnel plots. As shown in Fig. S7, the shape of the funnel plots revealed asymmetry in some degree due to the limited number of literatures. Then, Egger’s linear regression test was used to provide statistical evidence of funnel plots asymmetry. For CD209 -336A/G polymorphism, the P values of Egger’s linear regression test were 0.789, 0.880, 0.951, and 0.606 for G vs. A, GG vs. AA, dominant genetic model, and recessive genetic model, respectively. For CD209 -871A/G polymorphism, the P values were 0.779, 0.117, 0.516, and 0.302, respectively. The result still did not suggest any evidence of publication bias.

Discussion

According to WHO, The estimates of TB global burden were 9.4 million incident cases, 14 million prevalent cases, and 1.68 million deaths (with 0.38 million in HIV-positive individuals) in 2009 [21]. So, it is necessary to explore the infection mechanism. Clearly, the genetic contribution of the host plays a significant role in determining susceptibility to TB [22]. The CD209 gene, encoding DC-SIGN, might play a crucial role in the pathogenesis of TB. The association between CD209 gene polymorphisms and TB risk was first reported in a South African populations by Barreiro et al [6]; however, as discussed above, conflicting data regarding the role of CD209 in TB susceptibility and presentation have been reported [12]–[15], [19]. Against this backdrop, we performed a meta-analysis to clarify the relationship between CD209 polymorphisms and TB risk.

In this meta-analysis, 14 studies (14 subgroups for -336A/G polymorphism, 4 subgroups for -871A/G polymorphism) on CD209 gene were performed to provide the most comprehensive assessment of the relationship between polymorphisms and TB. For CD209 -336A/G polymorphism, the G allele of -336A/G polymorphism had no association with the TB susceptibility for the G vs. A, GG vs. AA, dominant genetic model, and recessive genetic model in overall populations. For the CD209 -871A/G polymorphism, lack of an association was also found. Currently, many meta-analyses have reported the association between gene polymorphisms and TB susceptibility. Compared with the CD209 gene polymorphisms, the interferon-γ (IFN-γ), natural resistance-associated macrophage protein 1(NRAMP1), and Vitamin D receptor (VDR) gene polymorphisms contribute to susceptibility to TB [23]–[25]. The P2X7, Mannose-binding lectin 2 (MBL2), tumor necrosis factor-α (TNF-α), and Interleukin-10 (IL-10) gene polymorphisms are not associated with TB risk [26]–[29].

In view of the complex effect of genetic polymorphisms on disease progression, the lack of an association between CD209 polymorphisms and TB susceptibility may attribute to other polymorphisms in CD209 gene promoter which could affect the expression of DC-SIGN. In current study, we also performed meta-analysis to identify the association between CD209 -939G/A polymorphism and TB risk. There was no association between CD209 -939G/A polymorphism and TB risk (Fig. S8). de Wit E et al. [30] found that two interactions (DC-SIGN -871 A/G: NRAMP1(GT)_n repeat and DC-SIGN -871 A/G:MBL) influenced the risk of developing TB. Thus, the interaction between gene and gene might play a crucial role in the association of CD209 polymorphisms with TB risk.

Due to different racial or ethnic populations with different frequencies of alleles, different genetic backgrounds may affect TB susceptibilities. Therefore, subgroup analyses were performed according to ethnicity. First, we detected whether there was G allele frequency of variation in different ethnicities. For CD209 -336A/G polymorphism, the G allele frequency has significant differences in different populations. Next, the association between CD209 -336A/G polymorphism and different ethnicities was explored. The significant association was revealed for Asians in GG vs. AA (OR = 2.48, 95% CI = 1.46–4.22, P = 0.0008) and GG vs. AG+AA (OR = 2.10, 95% CI = 1.33–3.32, P = 0.001). The ethic-dependent association may attribute to interplay among different human alleles, locally predominant, and endemic mycobacterial lineages [31]. Ogarkov et al. [17] demonstrated that the G allele of CD209 -336A/G polymorphism could increase the risk of infection with Mycobacterium tuberculosis Beijing but not non-Beijing strain in Russian male population. Thus, the TB in different host infected with the same genotype may manifest as different outcome in clinic.

In our meta-analysis, obvious heterogeneity was observed for CD209 -336A/G polymorphism. Then, we used the Galbraith plots to explore the sources of heterogeneity. We found all of the I² values were less than 50% and P_{heterogeneity} were greater than 0.1 after excluding the studies of Zhuang et al., Vannberg FO(a) et al. and Barreiro LB et al, respectively. The results indicated that the three studies might be the major source of the heterogeneity for the CD209 -336A/G polymorphism. The results of subgroup analyses revealed that the ethnicity and sample type might contribute to the potential heterogeneity. Owing to the limited number of studies in this meta-analysis, we restricted meta-regression analysis to four factors (sample size, control source, NOS scores, and the frequency of G allele), which are the most likely to cause the heterogeneity between studies. However, the four above-mentioned factors had no significant impact on the heterogeneity.

There are some limitations to this meta-analysis. Firstly, the retrieved literature is potentially not comprehensive enough. We did not track the unpublished articles to obtain data for analysis. The potential effect of this publication bias is unknown. Secondly, the small sample sizes in some subgroup analyses may have limited statistical power to estimate the possible risk for CD209 polymorphisms. Thirdly, TB is a multifactorial disease and potential interactions among gene-gene and gene-environment should be considered. Moreover, as many other factors such as age or gender may participate in the progression of TB, we did not carry out subgroup analysis based on these factors due to limited data.

Conclusively, the CD209 promoter polymorphisms (-336A/G, -871A/G) may lack association with genetic susceptibility of TB. However, genotype GG of CD209 -336A/G polymorphism might play a role as risk factor for Asians in GG vs. AA and GG vs. AG+AA, which indicated the different genetic backgrounds may affect TB susceptibilities. Moreover, further studies with large sample size of different ethnic populations will be necessary to combine genetic factors together with poor economic conditions, malnutrition, stress and overcrowding.

Materials and Methods

Data Sources and Search Strategy

This meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) criteria [32]. Two investigators (K.C. and S.D.) independently performed a systematic electronic search of the PubMed, Embase, Web of Science, Weipu, and CBM databases for original articles published until 1 December, 2011 to identify potentially relevant articles and abstracts. Search terms used were “CD209 or DC-SIGN” and “tuberculosis or TB” and “polymorphism or mutation or variant”. There were no language restrictions. We reviewed the bibliographies of all selection articles to identify additional relevant studies.

Selection of Publications

Two reviewers (K.C. and W.L.) independently screened titles and abstracts of all studies for relevancy. Disagreements were resolved by a third opinion (M.C.). Full-text publications were retrieved for relevant articles. The strength of the individual studies was weighed for relevance, based on the following items: (1) evaluation of the CD209 -336A/G or -871A/G polymorphisms and TB risk, (2) case-control studied (family-based study design with linkage considerations was excluded), (2) sufficient data for estimating an odds ratio (OR) with 95% confidence intervals (CIs), (3) genotype distribution of control population in Hardy-Weinberg equilibrium (HWE), and (4) studies written in English or Chinese. For the studies with the same or overlapping data by the same authors, the most recent or largest population was selected.

Data Extraction

Data were extracted independently from each study by two reviewers (K.C. and S.D.) according to the inclusion criteria listed above. Agreement was reached after discussion for conflicting data. The following data were collected from each study: first author’s name, publication year, original country, ethnicity, sample size, sample types, TB definition, genotyping method, and genotype number in cases and controls.

Quality Assessment

The quality of included studies was assessed independently by the same two investigators using the Newcastle-Ottawa Scale (NOS) (Stang A., 2010). The NOS uses a ‘star’ rating system to judge quality based on 3 aspects of the study: selection, comparability, and exposure. Scores were ranged from 0 stars (worst) to 9 stars (best). Studies with a score of 7 stars or greater were considered to be of high quality. Disagreement was settled as described above.

Statistical Analysis

The strength of association between CD209 polymorphisms and TB risk was estimated by OR and corresponding 95% CIs. The pooled OR was calculated respectively for G vs. A, GG vs. AA, dominant genetic model (GG+AG vs. AA), and recessive genetic model (GG vs. AG+AA). Between-study heterogeneity was assessed by the Q-test and I² test, P_{heterogeneity}<0.10 and I²>50% indicated evidence of heterogeneity. Then, the random-effects model (the DerSimonian and Laird method) [33]–[34] was used to calculate the pooled OR. Otherwise, the fixed-effects model (Mantel-Haenszel) [35] was adopted. Subgroup analyses and meta-regression were used to analyze the sources of heterogeneity.

Sensitivity analysis was mainly performed to assess the stability of the results, namely, a single study in the meta-analysis was deleted each time to reflect the influence of the individual data set to the pooled OR. Asymmetry funnel plots were inspected to assess potential publication bias. The Egger’s linear regression test [36] was also used to assess publication bias statistically.

Data were analyzed by using STATA 11.0 (Stata Corporation, College Station, TX, USA) and Revman 5.0 (The Cochrane Collaboration).

Supporting Information

[Figure omitted. See PDF.]

Figure S1.

Flow diagram of the selection of eligible studies.

https://doi.org/10.1371/journal.pone.0041519.s001

(TIF)

Figure S2.

Frequencies of the minor allele (G allele) of the CD209 -336A/G polymorphism among controls subjects stratified by ethnicity. The G allele frequencies were significant difference in Africans, Asians, Caucasians and Mixed populations (P = 0.007)

https://doi.org/10.1371/journal.pone.0041519.s002

(TIF)

Figure S3.

Forest plot of CD209 -336A/G promoter polymorphism and risk of TB in G vs. A for each subgroup. No significant association was found between the CD209 -336A/G polymorphism and TB risk in G vs. A.

https://doi.org/10.1371/journal.pone.0041519.s003

(TIF)

Figure S4.

Forest plot of CD209 -336A/G promoter polymorphism and risk of TB in GG vs. AA for each subgroup. The significant association was revealed for Asians in GG vs. AA (OR = 2.48, 95% CI = 1.46–4.22, P = 0.0008).

https://doi.org/10.1371/journal.pone.0041519.s004

(TIF)

Figure S5.

Forest plot of CD209 -336A/G promoter polymorphism and risk of TB in dominant model for each subgroup. No significant association was found between the CD209 -336A/G polymorphism and TB risk in dominant model.

https://doi.org/10.1371/journal.pone.0041519.s005

(TIF)

Figure S6.

Forest plot of CD209 -336A/G promoter polymorphism and risk of TB in recessive model for each subgroup. The significant association was revealed for Asians in recessive model (OR = 2.10, 95% CI = 1.33–3.32, P = 0.001).

https://doi.org/10.1371/journal.pone.0041519.s006

(TIF)

Figure S7.

Funnel plots of all genetic models in overall studies. A. G vs. A; B. GG vs. AA; C. dominant model (GG+AG vs. AA); D. recessive model (GG vs. AG+AA). Funnel plots of dominant model seemed asymmetry. Each point represents a separate study for the indicated association.

https://doi.org/10.1371/journal.pone.0041519.s007

(TIF)

Figure S8.

Forest plot of the overall risk of TB associated with the CD209 -939G/A promoter polymorphism. No significant association was found between the CD209 -939G/A polymorphism and TB risk in all genetic models. Error bars indicate 95% CI. Solid squares represent each study in the meta-analysis. Solid diamonds represent pooled OR.

https://doi.org/10.1371/journal.pone.0041519.s008

(TIF)

Table S1.

Gene frequencies of all the individual studies used for the meta-analysis.

https://doi.org/10.1371/journal.pone.0041519.s009

(DOC)

Table S2.

Quality assessment of included studies.

https://doi.org/10.1371/journal.pone.0041519.s010

(DOC)

Table S3.

Meta-regression analysis of CD209 -336A/G promoter polymorphism and risk of TB after omitting the studies.

https://doi.org/10.1371/journal.pone.0041519.s011

(DOC)

Author Contributions

Analyzed the data: KC FW SRJ FKL. Wrote the paper: KC MC LLY. Conceived and designed the meta-analysis: MC KC LLY. Performed a systematic electronic search of databases and extracted the data: KC SLD MC. Screened titles and abstracts of all studies for relevancy: KC WPL MC. Assessed the quality of included studies: KC SLD MC.

Citation: Chang K, Deng S, Lu W, Wang F, Jia S, Li F, et al. (2012) Association between CD209 -336A/G and -871A/G Polymorphisms and Susceptibility of Tuberculosis: A Meta-Analysis. PLoS ONE 7(7): e41519. https://doi.org/10.1371/journal.pone.0041519

References

1. Connell DW, Berry M, Cooke G, Kon OM (2011) Update on tuberculosis: TB in the early 21st century. Eur Respir Rev 20: 71–84.DW ConnellM. BerryG. CookeOM Kon2011Update on tuberculosis: TB in the early 21st century.Eur Respir Rev207184

2. Organization WH (2010) Global Tuberculosis Control 2010.WHO/HTM/TB/2010.7. Geneva, World Health Organization. Organization WH2010Global Tuberculosis Control 2010.WHO/HTM/TB/2010.7.Geneva, World Health Organization

3. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009–1021.EL CorbettCJ WattN. WalkerD. MaherBG Williams2003The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.Arch Intern Med16310091021

4. Hill AV (2006) Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 40: 469–486.AV Hill2006Aspects of genetic susceptibility to human infectious diseases.Annu Rev Genet40469486

5. Jepson A, Fowler A, Banya W, Singh M, Bennett S, et al. (2001) Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect Immun 69: 3989–3994.A. JepsonA. FowlerW. BanyaM. SinghS. Bennett2001Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.Infect Immun6939893994

6. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al. (2006) Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3: e20.LB BarreiroO. NeyrollesCL BabbL. TailleuxH. Quach2006Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.PLoS Med3e20

7. Soilleux EJ, Barten R, Trowsdale J (2000) DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 165: 2937–2942.EJ SoilleuxR. BartenJ. Trowsdale2000DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13.J Immunol16529372942

8. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, et al. (2003) DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197: 121–127.L. TailleuxO. SchwartzJL HerrmannE. PivertM. Jackson2003DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.J Exp Med197121127

9. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, et al. (2003) Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197: 7–17.TB GeijtenbeekSJ Van VlietEA KoppelM. Sanchez-HernandezCM Vandenbroucke-Grauls2003Mycobacteria target DC-SIGN to suppress dendritic cell function.J Exp Med197717

10. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, et al. (2000) DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 1: 353–357.TB GeijtenbeekDJ KrooshoopDA BleijsSJ van VlietGC van Duijnhoven2000DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.Nat Immunol1353357

11. Gomez LM, Anaya JM, Sierra-Filardi E, Cadena J, Corbi A, et al. (2006) Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol 67: 808–811.LM GomezJM AnayaE. Sierra-FilardiJ. CadenaA. Corbi2006Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis.Hum Immunol67808811

12. Kobayashi K, Yuliwulandari R, Yanai H, Lien LT, Hang NTL, et al. (2011) Association of CD209 polymorphisms with tuberculosis in an Indonesian population. Hum Immunol 72: 741–745.K. KobayashiR. YuliwulandariH. YanaiLT LienNTL Hang2011Association of CD209 polymorphisms with tuberculosis in an Indonesian population.Hum Immunol72741745

13. Selvaraj P, Alagarasu K, Swaminathan S, Harishankar M, Narendran G (2009) CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. Infect Genet Evol 9: 256–262.P. SelvarajK. AlagarasuS. SwaminathanM. HarishankarG. Narendran2009CD209 gene polymorphisms in South Indian HIV and HIV-TB patients.Infect Genet Evol9256262

14. Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, et al. (2008) CD209 genetic polymorphism and tuberculosis disease. PLoS One 3: e1388.FO VannbergSJ ChapmanCC KhorK. ToshS. Floyd2008CD209 genetic polymorphism and tuberculosis disease.PLoS One3e1388

15. Sadki K, Lamsyah H, Rueda B, Lahlou O, El Aouad R, et al. (2009) CD209 Promoter Single Nucleotide Polymorphism-336A/G and the Risk of Susceptibility to Tuberculosis Disease in the Moroccan Population. Int J Hum Genet 9: 239–243.K. SadkiH. LamsyahB. RuedaO. LahlouR. El Aouad2009CD209 Promoter Single Nucleotide Polymorphism-336A/G and the Risk of Susceptibility to Tuberculosis Disease in the Moroccan Population.Int J Hum Genet9239243

16. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, et al. (2007) DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 8: 456–467.R. OlesenC. WejseDR VelezC. BisseyeM. Sodemann2007DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans.Genes Immun8456467

17. Ogarkov O, Mokrousov I, Sinkov V, Zhdanova S, Antipina S, et al. (2012) 'Lethal' combination of Mycobacterium tuberculosis Beijing genotype and human CD209–336G allele in Russian male population. Infect Genet Evol 12: 732–736.O. OgarkovI. MokrousovV. SinkovS. ZhdanovaS. Antipina2012'Lethal' combination of Mycobacterium tuberculosis Beijing genotype and human CD209–336G allele in Russian male population.Infect Genet Evol12732736

18. Ben-Ali M, Barreiro LB, Chabbou A, Haltiti R, Braham E, et al. (2007) Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients. Hum Immunol 68: 908–912.M. Ben-AliLB BarreiroA. ChabbouR. HaltitiE. Braham2007Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients.Hum Immunol68908912

19. Zheng R, Zhou Y, Qin L, Jin R, Wang J, et al. (2011) Relationship between polymorphism of DC-SIGN (CD209) gene and the susceptibility to pulmonary tuberculosis in an eastern Chinese population. Hum Immunol 72: 183–186.R. ZhengY. ZhouL. QinR. JinJ. Wang2011Relationship between polymorphism of DC-SIGN (CD209) gene and the susceptibility to pulmonary tuberculosis in an eastern Chinese population.Hum Immunol72183186

20. Zhuang B, Yang BF, Song HM, Li F, Kong LB (2009) Study on correlation between CD209 polymorphisms and susceptibility to pulmonary tuberculosis. Clin J Public Health 25: 517–519.B. ZhuangBF YangHM SongF. LiLB Kong2009Study on correlation between CD209 polymorphisms and susceptibility to pulmonary tuberculosis.Clin J Public Health25517519

21. Yew WW, Sotgiu G, Migliori GB (2011) Update in tuberculosis and nontuberculous mycobacterial disease 2010. Am J Respir Crit Care Med 184: 180–185.WW YewG. SotgiuGB Migliori2011Update in tuberculosis and nontuberculous mycobacterial disease 2010.Am J Respir Crit Care Med184180185

22. Cooke GS, Hill AV (2001) Genetics of susceptibility to human infectious disease. Nat Rev Genet 2: 967–977.GS CookeAV Hill2001Genetics of susceptibility to human infectious disease.Nat Rev Genet2967977

23. Tian C, Zhang Y, Zhang J, Deng Y, Li X, et al. (2011) The +874T/A polymorphism in the interferon-gamma gene and tuberculosis risk: an update by meta-analysis. Hum Immunol 72: 1137–1142.C. TianY. ZhangJ. ZhangY. DengX. Li2011The +874T/A polymorphism in the interferon-gamma gene and tuberculosis risk: an update by meta-analysis.Hum Immunol7211371142

24. Li X, Yang Y, Zhou F, Zhang Y, Lu H, et al. (2011) SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One 6: e15831.X. LiY. YangF. ZhouY. ZhangH. Lu2011SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis.PLoS One6e15831

25. Gao L, Tao Y, Zhang L, Jin Q (2010) Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 14: 15–23.L. GaoY. TaoL. ZhangQ. Jin2010Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis.Int J Tuberc Lung Dis141523

26. Zhang J, Chen Y, Nie XB, Wu WH, Zhang H, et al. (2011) Interleukin-10 polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 15: 594–601.J. ZhangY. ChenXB NieWH WuH. Zhang2011Interleukin-10 polymorphisms and tuberculosis susceptibility: a meta-analysis.Int J Tuberc Lung Dis15594601

27. Wang Q, Zhan P, Qiu LX, Qian Q, Yu LK (2012) TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies. Mol Biol Rep. 39: 3393–3400.Q. WangP. ZhanLX QiuQ. QianLK Yu2012TNF-308 gene polymorphism and tuberculosis susceptibility: a meta-analysis involving 18 studies. Mol Biol Rep.3933933400

28. Xiao J, Sun L, Yan H, Jiao W, Miao Q, et al. (2010) Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility. FEMS Immunol Med Microbiol 60: 165–170.J. XiaoL. SunH. YanW. JiaoQ. Miao2010Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility.FEMS Immunol Med Microbiol60165170

29. Denholm JT, McBryde ES, Eisen DP (2010) Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol 162: 84–90.JT DenholmES McBrydeDP Eisen2010Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis.Clin Exp Immunol1628490

30. de Wit E, van der Merwe L, van Helden PD, Hoal EG (2011) Gene-gene interaction between tuberculosis candidate genes in a South African population.Mamm Genome 22: 100–110.E. de WitL. van der MerwePD van HeldenEG Hoal2011Gene-gene interaction between tuberculosis candidate genes in a South African population.Mamm Genome22100110

31. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, et al. (2008) The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 28: e1000034.M. CawsG. ThwaitesS. DunstanTR HawnNT Lan2008The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis.PLoS Pathog28e1000034

32. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.D. MoherA. LiberatiJ. TetzlaffDG Altman2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med6e1000097

33. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.R. DerSimonianN. Laird1986Meta-analysis in clinical trials.Control Clin Trials7177188

34. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28: 105–114.R. DerSimonianR. Kacker2007Random-effects model for meta-analysis of clinical trials: an update.Contemp Clin Trials28105114

35. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748.N. MantelW. Haenszel1959Statistical aspects of the analysis of data from retrospective studies of disease.J Natl Cancer Inst22719748

36. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.M. EggerG. Davey SmithM. SchneiderC. Minder1997Bias in meta-analysis detected by a simple, graphical test.BMJ315629634